Antiretroviral therapy improves survival in patients with HIV and multi-drug resistant tuberculosis

摘要

Background: South Africa has the fourth highest burden of multi-drug resistant tuberculosis (MDR TB) globally, further complicated by the high prevalence of HIV co-infection resulting in high morbidity and mortality. This study assessed the impact of combining antiretroviral therapy (ART) with TB treatment, on mortality in HIV-infected patients with MDR TB.